Table 1 Clinical characteristics of the study population (total n = 157).
From: The added value of anosmic subtype on motor subtype in Parkinson’s disease: a pilot study
Median | IQR | |
|---|---|---|
Age | 67.0 | 14.0 |
Sex | ||
Male, n(%) | 97 | 61.8 |
Female, n(%) | 60 | 38.2 |
Age at onset | 64.0 | 15.0 |
Duration, month | 24.0 | 53.0 |
Education, year | 9.0 | 7.0 |
LEDD, mg | 350.0 | 495.0 |
UPSIT | 16.0 | 11.0 |
M-UPDRS score | ||
Total | 47.0 | 29.5 |
Cognition | ||
MoCA | 26.0 | 7.0 |
PDQ-39 SI | 16.0 | 20.5 |
TRODAT | ||
TRODAT sum score | 5.0 | 2.0 |
Time to evaluation, month | 1.0 | 2.0 |
Motor subtype | ||
PIGD, n(%) | 87 | 55.4 |
IND, n(%) | 11 | 7.0 |
TDPD, n(%) | 59 | 37.6 |
Olfactory subtype | ||
Total anosmia (TA), n(%) | 94 | 59.9 |
Non-anosmia (NA), n(%) | 63 | 40.1 |
Motor & olfactory subtype | ||
PIGD TA, n(%) | 55 | 35.0 |
PIGD NA, n(%) | 32 | 20.4 |
TDPD TA, n(%) | 34 | 21.7 |
TDPD NA, n(%) | 25 | 15.9 |
Other, n(%) | 11 | 7.0 |
